These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14697989)

  • 1. Thyroid, parathyroid, gonadal, and pancreatic beta-cell function after bone marrow transplantation with chemotherapy-only conditioning.
    Ghavamzadeh A; Larijani B; Jahani M; Khoshniat M; Bahar B; Tabatabaei O
    Transplant Proc; 2003 Dec; 35(8):3101-4. PubMed ID: 14697989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of thyroid and adrenocortical functions after bone marrow transplantation with MAC conditioning regimen in leukemia patients].
    Ma Y; Qiao Z; Yang L
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):402-4. PubMed ID: 11189505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal function after bone marrow transplantation for acute leukemia during childhood.
    Sarafoglou K; Boulad F; Gillio A; Sklar C
    J Pediatr; 1997 Feb; 130(2):210-6. PubMed ID: 9042122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal long-term parathyroid function after autologous bone marrow transplantation in children.
    Frisk P; Arvidson J; Stridsberg M; Gustafsson J
    Pediatr Transplant; 2007 Mar; 11(2):205-8. PubMed ID: 17300502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide.
    Afify Z; Shaw PJ; Clavano-Harding A; Cowell CT
    Bone Marrow Transplant; 2000 May; 25(10):1087-92. PubMed ID: 10828870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients.
    Chatterjee R; Mills W; Katz M; McGarrigle HH; Goldstone AH
    Bone Marrow Transplant; 1994 May; 13(5):511-7. PubMed ID: 8054904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
    Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
    J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and endocrine function following bone marrow transplantation for thalassemia.
    De Simone M; Olioso P; Di Bartolomeo P; Di Girolamo G; Farello G; Palumbo M; Papalinetti G; Bavaro P; Angrilli F; Torlontano G
    Bone Marrow Transplant; 1995 Feb; 15(2):227-33. PubMed ID: 7773211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal Langerhans cells after allogeneic bone marrow transplantation: depletion by chemotherapy conditioning regimen alone.
    Zambruno G; Girolomoni G; Manca V; Andreani M; Galimberti M; Lucarelli G; Giannetti A
    J Cutan Pathol; 1992 Jun; 19(3):187-92. PubMed ID: 1383297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal function of young patients with beta-thalassemia following bone marrow transplantation.
    Vlachopapadopoulou E; Kitra V; Peristeri J; Goussetis E; Karachaliou F; Petropoulos D; Fotinou A; Michalacos S; Graphakos S
    J Pediatr Endocrinol Metab; 2005 May; 18(5):477-83. PubMed ID: 15921177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in thyroid function after bone marrow transplant in young patients.
    Matsumoto M; Ishiguro H; Tomita Y; Inoue H; Yasuda Y; Shimizu T; Shinagawa T; Hattori K; Yabe H; Kubota C; Yabe M; Kato S; Shinohara O
    Pediatr Int; 2004 Jun; 46(3):291-5. PubMed ID: 15151545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
    Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning.
    Shankar SM; Bunin NJ; Moshang T
    J Pediatr Hematol Oncol; 1996 Nov; 18(4):362-6. PubMed ID: 8888742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
    Reece DE; Barnett MJ; Connors JM; Klingemann HG; O'Reilly SE; Shepherd JD; Sutherland HJ; Phillips GL
    Bone Marrow Transplant; 1993 Feb; 11(2):139-46. PubMed ID: 8435663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
    Michel G; Socié G; Gebhard F; Bernaudin F; Thuret I; Vannier JP; Demeocq F; Leverger G; Pico JL; Rubie H; Mechinaud F; Reiffers J; Gratecos N; Troussard X; Jouet JP; Simonin G; Gluckman E; Maraninchi D
    J Clin Oncol; 1997 Jun; 15(6):2238-46. PubMed ID: 9196136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood.
    Liesner RJ; Leiper AD; Hann IM; Chessells JM
    J Clin Oncol; 1994 May; 12(5):916-24. PubMed ID: 8164042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.
    Locatelli F; Pession A; Bonetti F; Maserati E; Prete L; Pedrazzoli P; Zecca M; Prete A; Paolucci P; Cazzola M
    Leukemia; 1994 May; 8(5):844-9. PubMed ID: 8182940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting gonadal function after bone marrow transplantation during childhood.
    Couto-Silva AC; Trivin C; Thibaud E; Esperou H; Michon J; Brauner R
    Bone Marrow Transplant; 2001 Jul; 28(1):67-75. PubMed ID: 11498747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
    Kato K; Yoshida N; Matsumoto K; Matsuyama T
    Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.